Skip to main content
. 2021 Apr 9;14:101058. doi: 10.1016/j.bonr.2021.101058

Fig. 5.

Fig. 5

Bone turnover markers ALP, P1NP and CTX before and during bisphosphonate (BP) and denosumab (Dmab) treatment of case 2. Arrowheads indicate the denosumab injections. ULN: upper limit of normal.